Dacarbazine for Injection
| General Information: Dacarbazine
for Injection is typically utilized in the treatment of metastatic malignant melanoma and Hodgkins disease. For indication, dosing and other information, please refer to the manufacture package insert. |
| |
| Manufacturer |
Product |
Size |
NDC |
PI |
MSDS |
| Hospira |
Dacarbazine |
200 mg/20 mL |
61703-0327-22 |
PI |
MSDS |
|
|
|
|
|
|
|
|
TEVA |
Dacarbazine
|
200 mg/20 mL |
00703-5075-01 |
PI |
MSDS |
|
|
|
200 mg/20 mL
(10 pack) |
00703-5705-03 |
PI |
MSDS |
|
| |
| Clinical
Data: For any questions
or for further information
related to Dacarbazine for
Injection, clinical
pharmacology, additional
indications and usages,
contraindications, warnings,
precautions, adverse reactions,
dosage, administration and/or
storage of this product, please
contact
BDI Pharma or call 1-800-948-9834. |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |